Tranexamic Acid may reduce deaths in traumatic brain injury patients by as much as 20%, depending on the severity of the injury, according to a major study published in The Lancet. Tranexamic Acid prevents bleeding into the brain by inhibiting blood clot breakdown and has the potential to save hundreds of thousands of lives. Researchers at the London School of Hygiene & Tropical Medicine have found that administration of Tranexamic Acid within three hours of head injury reduced the number of deaths.
This effect was greatest in patients with mild and moderate traumatic brain injury (20% reduction in deaths), while no clear benefit was seen in the most severely injured patients. The trial found no evidence of adverse effects and there was no increase in disability in survivors when the drug was used. Traumatic brain injury (TBI) is a leading cause of death and disability worldwide with an…
